These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 20576364

  • 1. Double-blind fluoxetine trial in comorbid MDD-CUD youth and young adults.
    Cornelius JR, Bukstein OG, Douaihy AB, Clark DB, Chung TA, Daley DC, Wood DS, Brown SJ.
    Drug Alcohol Depend; 2010 Nov 01; 112(1-2):39-45. PubMed ID: 20576364
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Double-blind placebo-controlled trial of fluoxetine in adolescents with comorbid major depression and an alcohol use disorder.
    Cornelius JR, Bukstein OG, Wood DS, Kirisci L, Douaihy A, Clark DB.
    Addict Behav; 2009 Oct 01; 34(10):905-9. PubMed ID: 19321268
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
    Sonawalla SB, Farabaugh A, Johnson MW, Morray M, Delgado ML, Pingol MG, Rosenbaum JF, Fava M.
    J Psychopharmacol; 2002 Sep 01; 16(3):215-9. PubMed ID: 12236627
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.
    Goodyer IM, Dubicka B, Wilkinson P, Kelvin R, Roberts C, Byford S, Breen S, Ford C, Barrett B, Leech A, Rothwell J, White L, Harrington R.
    Health Technol Assess; 2008 May 01; 12(14):iii-iv, ix-60. PubMed ID: 18462573
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of Bright Light Treatment, Fluoxetine, and the Combination in Patients With Nonseasonal Major Depressive Disorder: A Randomized Clinical Trial.
    Lam RW, Levitt AJ, Levitan RD, Michalak EE, Cheung AH, Morehouse R, Ramasubbu R, Yatham LN, Tam EM.
    JAMA Psychiatry; 2016 Jan 01; 73(1):56-63. PubMed ID: 26580307
    [Abstract] [Full Text] [Related]

  • 12. Fluoxetine versus placebo in depressed alcoholics: a 1-year follow-up study.
    Cornelius JR, Salloum IM, Haskett RF, Daley DC, Cornelius MD, Thase ME, Perel JM.
    Addict Behav; 2000 Jan 01; 25(2):307-10. PubMed ID: 10795957
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cannabis withdrawal is common among treatment-seeking adolescents with cannabis dependence and major depression, and is associated with rapid relapse to dependence.
    Cornelius JR, Chung T, Martin C, Wood DS, Clark DB.
    Addict Behav; 2008 Nov 01; 33(11):1500-1505. PubMed ID: 18313860
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): study protocol for a randomised control trial.
    Davey CG, Chanen AM, Cotton SM, Hetrick SE, Kerr MJ, Berk M, Dean OM, Yuen K, Phelan M, Ratheesh A, Schäfer MR, Amminger GP, Parker AG, Piskulic D, Harrigan S, Mackinnon AJ, Harrison BJ, McGorry PD.
    Trials; 2014 Nov 04; 15():425. PubMed ID: 25370185
    [Abstract] [Full Text] [Related]

  • 18. Do comorbid social and other anxiety disorders predict outcomes during and after cognitive therapy for depression?
    Vittengl JR, Clark LA, Smits JAJ, Thase ME, Jarrett RB.
    J Affect Disord; 2019 Jan 01; 242():150-158. PubMed ID: 30176494
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparative efficacy, acceptability, and safety of medicinal, cognitive-behavioral therapy, and placebo treatments for acute major depressive disorder in children and adolescents: a multiple-treatments meta-analysis.
    Ma D, Zhang Z, Zhang X, Li L.
    Curr Med Res Opin; 2014 Jun 01; 30(6):971-95. PubMed ID: 24188102
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.